IGM Biosciences : Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Data from T cell Engager Portfolio for Hematologic Malignancies, Including First... | November 3, 2022